Cargando…

The Effect of Tenofovir on Vitamin D Metabolism in HIV-Infected Adults Is Dependent on Sex and Ethnicity

BACKGROUND: Tenofovir has been associated with renal phosphate wasting, reduced bone mineral density, and higher parathyroid hormone levels. The aim of this study was to carry out a detailed comparison of the effects of tenofovir versus non-tenofovir use on calcium, phosphate and, vitamin D, parathy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klassen, Karen, Martineau, Adrian R., Wilkinson, Robert J., Cooke, Graham, Courtney, Alan P., Hickson, Mary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440360/ https://www.ncbi.nlm.nih.gov/pubmed/22984574 http://dx.doi.org/10.1371/journal.pone.0044845

Ejemplares similares

Anti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIV
por: Coussens, Anna K., et al.
Publicado: (2014)

Tenofovir use is associated with low vitamin D levels in a Spanish HIV cohort
por: Cervero, M, et al.
Publicado: (2010)

Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity
por: Walti, Laura N, et al.
Publicado: (2018)

Adherence Predictors in Pregnant Women Living with HIV on Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate
por: Eke, Ahizechukwu C
Publicado: (2022)

Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA
por: Michailidis, Eleftherios, et al.
Publicado: (2013)

Differential Effects of Oral Boluses of Vitamin D(2) vs Vitamin D(3) on Vitamin D Metabolism: A Randomized Controlled Trial
por: Martineau, Adrian R, et al.
Publicado: (2019)

Estimated changes in price discounts for tenofovir-inclusive HIV treatments following introduction of tenofovir alafenamide
por: Dickson, Sean, et al.
Publicado: (2022)

No association between vitamin D deficiency and parathyroid hormone, bone density and bone turnover in a large cohort of HIV-infected men on tenofovir
por: Samarawickrama, Amanda, et al.
Publicado: (2014)

Phenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D₃
por: Coussens, Anna K., et al.
Publicado: (2015)

Pregnancy Outcomes in Pregnant Women with HIV on Tenofovir Disoproxil Fumarate (TDF) Compared to Tenofovir Alafenamide (TAF)
por: Thimm, Matthew A., et al.
Publicado: (2022)

Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue
por: Else, Laura, et al.
Publicado: (2022)

Vitamin D metabolic loci and preeclampsia risk in multi‐ethnic pregnant women
por: Baca, Katharyn M., et al.
Publicado: (2018)

Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization
por: Brunet, Laurence, et al.
Publicado: (2021)

Milk Calcium and Phosphorus in Ugandan Women with HIV on Tenofovir-Based Antiretroviral Therapy
por: Nabwire, Florence, et al.
Publicado: (2023)

An overview of tenofovir and renal disease for the HIV-treating clinician
por: Venter, Willem D.F., et al.
Publicado: (2018)

A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
por: Wassner, Chanie, et al.
Publicado: (2020)

Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men
por: Mizushima, Daisuke, et al.
Publicado: (2023)

Corticosteroid Therapy, Vitamin D Status, and Inflammatory Cytokine Profile in the HIV-Tuberculosis Immune Reconstitution Inflammatory Syndrome
por: Conesa-Botella, Anali, et al.
Publicado: (2012)

1591 Hepatitis B outcome in coinfected HIV-HBV individuals in the tenofovir/emtricitabine era
por: Nguyen, Divien, et al.
Publicado: (2014)

The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis
por: Wang, Huilian, et al.
Publicado: (2016)

Proximal tubular renal dysfunction among HIV infected patients on Tenofovir versus Tenofovir sparing regimen in western Kenya
por: Karoney, Mercy Jelagat, et al.
Publicado: (2022)

Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV
por: Devred, Inès, et al.
Publicado: (2023)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
por: Kawuma, Aida N., et al.
Publicado: (2023)

Vitamin D for COVID-19: where are we now?
por: Martineau, Adrian R., et al.
Publicado: (2022)

Ganciclovir–tenofovir interaction leading to tenofovir-induced nephrotoxicity
por: Soanker, Radhika, et al.
Publicado: (2014)

Population pharmacokinetics of tenofovir and tenofovir‐diphosphate in healthy women
por: Burns, Rebecca N., et al.
Publicado: (2015)

Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing
por: Johnson, Kelly A, et al.
Publicado: (2021)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate‐Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
por: Bukkems, Vera E., et al.
Publicado: (2020)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings
por: Thurman, Andrea Ries, et al.
Publicado: (2019)

Drug Synergy of Tenofovir and Nanoparticle-Based Antiretrovirals for HIV Prophylaxis
por: Chaowanachan, Thanyanan, et al.
Publicado: (2013)

Focal bone lesions in hiv-positive patient treated with tenofovir
por: Mangioni, Davide, et al.
Publicado: (2014)

Effect of Tenofovir on Nucleotidases and Cytokines in HIV-1 Target Cells
por: Biswas, Nabanita, et al.
Publicado: (2013)

The effect of tenofovir on renal function in HIV-positive pregnant women
por: Flanagan, Stuart, et al.
Publicado: (2014)

376. COVID-19 Severity in HIV+ Patients Receiving Tenofovir
por: Homsi, Nora, et al.
Publicado: (2020)

Tenofovir Concentration Is Not Enough in Intraocular Tissues of Patients With HIV infection
por: Qian, Yiwen, et al.
Publicado: (2023)

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans
por: Mateza, Somila, et al.
Publicado: (2023)

Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV
por: Puri, Ashana, et al.
Publicado: (2019)

Sharpening the global focus on ethnicity and race in the time of COVID-19
por: Bhala, Neeraj, et al.
Publicado: (2020)

Modulation of the Immune Response to Respiratory Viruses by Vitamin D
por: Greiller, Claire L., et al.
Publicado: (2015)

Vitamin D for COVID-19: a case to answer?
por: Martineau, Adrian R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_olskhakf0o00sjucviq6i4kova